Cationic lipid-DNA complexes in gene delivery: From biophysics to biological applications

Advanced Drug Delivery Reviews

Volumn 47, Issue 2-3, 2001, Pages 277-294

  Pedroso De Lima, Maria C ^b,c   Simões, Sérgio ^a,c   Pires, Pedro ^c   Faneca, Henrique ^c   Düzgüneş, Nejat ^d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Biological barriers; Gene therapy; Lipoplexes; Non viral vectors

Indexed keywords

DNA; GENES; MEDICINE;

GENE DELIVERY;

LIPIDS;

CATIONIC LIPOSOME; DNA; LIPOFECTIN; LIPOPLEXES; LIPOSOME; UNCLASSIFIED DRUG;

DRUG DISTRIBUTION; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW;

EID: 0035946624     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00110-7     Document Type: Article

References (93)

1. Cationic liposomes as gene transfer vectors: Barriers to successful application in gene therapy
2. Liposomes in gene therapy
3. DNA strongly binds to micelles and vesicles containing lipopolyamines or lipointercalants
4. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure
5. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations
6. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung
7. Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery
8. A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery
9. A novel cationic lipid reagent greatly enhances plasmid DNA delivery and expression in mouse lung
10. Novel cationic liposomes for DNA-transfection with high efficiency and low toxicity
11. Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC
12. Efficient gene transfer into mammalian primary endocrine cells with lipolyamine-coated-DNA
13. Analytical methods for the characterization of cationic lipid-nucleic acid complexes
14. Improved cationic lipid formulations for in vivo gene therapy
15. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung
16. The role of helper lipids in cationic liposome-mediated gene transfer
17. Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA
18. Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides
19. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery
20. Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery
21. Characterization of lipid DNA interactions. I. Destabilization of bound lipids and DNA dissociation
22. Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands and pH-sensitive peptides
23. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery
24. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery
25. Free liposomes enhance the transfection activity of DNA/lipid complexes in vivo by intravenous administration
26. Ultrastructural characterization of cationic liposome-DNA complexes showing enhanced stability in serum and high transfection activity in vivo
27. Stable and monodisperse lipoplex formulations for gene delivery
28. Lipoplex size is major determinant of in vitro lipofection efficiency
29. Evidence for three-dimensional interlayer correlations in cationic lipid-DNA complexes as observed by cryo-electron microscopy
30. Cationic liposomes mediate transfection
31. Mode of formation and structural features of DNA-cationic liposome complexes used for transfection
32. New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy
33. Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes
34. Multilamellar structures of DNA complexes with cationic liposomes
35. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery
36. DNA-lipid complexes: Stability of honeycomb-like and spaghetti-like structures
37. The structure of the DNA complexes with cationic liposomes-cylindrical or flat bilayers?
38. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin
39. Chiral DNA packaging in DNA-cationic liposome assemblies
40. Improved DNA: Liposome complexes for increased systemic delivery and gene expression
41. Two-dimensional condensation of DNA molecules on cationic lipid membranes
42. Recent developments in medical applications of liposomes: Sterically stabilized liposomes in cancer therapy and gene delivery in vivo
43. The effect of mixing on the formation of DNA/liposome complexes
44. Controllable gene therapy: Pharmaceutics of non-viral gene delivery systems
45. Biophysical characterization of cationic lipid: DNA complexes
46. Interaction of cationic liposomes and their DNA complexes with monocytic leukemia cells
47. Pharmaceutical approach to somatic gene therapy
48. Cationic lipid-based gene delivery systems: Pharmaceutical perspectives
49. Gene delivery
50. Simple mixing device to reproducibly prepare cationic lipid-DNA complexes (lipoplexes)
51. Characterization and in vivo testing of a heterogeneous cationic lipid-DNA formulation
52. Target specific optimization of cationic lipid-based systems for pulmonary gene therapy
53. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome and DNA
54. Time-dependent maturation of cationic liposome-DNA complex for serum resistance
55. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes
56. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery
57. Protamine sulfate enhances lipid-mediated gene transfer
58. Potentiation of cationic liposome-mediated gene delivery by polycations
59. Cellular and molecular barriers to gene transfer by a cationic lipid
60. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection
61. Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes
62. Fusion of cationic liposomes with mammalian cells occurs after endocytosis
63. Gene transfer mediated by cationic lipids: Lack of a correlation between lipid mixing and transfection
64. Parameters influencing the introduction of plasmid DNA into cells by the use of synthetic amphiphiles as a carrier system
65. Biological barriers to cellular delivery of lipid-based DNA carriers
66. Transfection of human macrophages by lipoplexes via the combined use of targeting ligands and fusogenic peptides
67. Enhanced gene delivery by lipoplexes associated with human serum albumin
68. Receptor ligand-facilitated gene transfer: Enhancement of liposome-mediated gene transfer and expression by transferrin
69. Kinetic analysis of the initial steps involved in lipoplex-cell interactions: Effect of various factors that influence transfection activity
70. Membrane fusion plays an important role in gene transfection mediated by cationic liposomes
71. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene-transfer vehicle
72. Influence of membrane-active peptides on lipospermine/DNA complex mediated gene transfer
73. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems
74. pH-dependent bilayer destabilization by an amphipathic peptide
75. Transgenesis in mice by cytoplasmic injection of polylysine/DNA mixtures
76. Signalling and transport through the nuclear membrane
77. Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy
78. Enhancement of polylysine-mediate transferrinfection by nuclear localization sequences: Polylysine does not function as a nuclear localization sequence
79. Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus
80. A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA
81. Cell-specific nuclear import of plasmid DNA
82. Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells
83. Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum
84. Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer
85. Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery
86. Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells
87. Efficient gene transfer by transferrin lipoplexes in the presence of serum
88. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration
89. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides
90. Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged circulation time
91. Lipid-based systems for the intracellular delivery of genetic drugs
92. Stabilized plasmid-lipid particles for regional gene therapy: Formulation and transfection properties
93. Stabilized plasmid-lipid particles: Construction and characterization